<DOC>
	<DOCNO>NCT00201903</DOCNO>
	<brief_summary>To explore relationship tissue factor level , tumour progression , activation blood coagulation venous thromboembolism malignant glioma</brief_summary>
	<brief_title>The Roles Tissue Factor Malignant Gliomas</brief_title>
	<detailed_description>To explore relationship tissue factor level , tumour progression , activation blood coagulation venous thromboembolism malignant glioma</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Thromboplastin</mesh_term>
	<criteria>participation PRODIGE adult patient newly diagnose , biopsyconfirmed grade III/IV malignant glioma undergone craniotomy stereotactic biopsy &gt; 2 day &lt; 4 week know hereditary thrombophilia receive experimental antiangiogenic therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>venous thromboembolism</keyword>
	<keyword>brain tumour</keyword>
	<keyword>glioma</keyword>
	<keyword>tissue factor</keyword>
	<keyword>blood coagulation</keyword>
	<keyword>tumour progression</keyword>
	<keyword>low molecular weight heparin</keyword>
</DOC>